Enzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2rjv4Ll
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Alkem subsidiary Enzene launches adalimumab biosimilar in India
0 comments:
Post a Comment